Ligand validation:2WS3

CBE: 2-METHYL-N-PHENYL-5,6-DIHYDRO-1,4-OXATHIINE-3-CARBOXAMIDE

CBE is a Ligand Of Interest in 2WS3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2WS3_CBE_C_1129	53%	11%	0.203	0.965	1.49	2.62	1	2	2	0	100%	1
2WS3_CBE_G_1129	30%	12%	0.295	0.96	1.55	2.53	4	3	0	0	100%	1
2WS3_CBE_K_1129	14%	14%	0.357	0.913	1.69	2.19	3	2	2	0	100%	1
2WU2_CBE_K_1131	84%	32%	0.113	0.975	1.3	1.4	2	1	0	0	100%	1
2WP9_CBE_C_1130	80%	20%	0.126	0.975	1.22	2.12	1	4	0	0	100%	1
2WDQ_CBE_G_1130	76%	25%	0.115	0.952	1.14	1.89	1	2	0	0	100%	1
2WU5_CBE_C_1130	70%	27%	0.153	0.971	1.11	1.83	1	2	0	0	100%	1
2FBW_CBE_P_202	82%	11%	0.12	0.975	2.2	1.99	3	3	2	0	100%	1
2WQY_CBE_P_202	76%	27%	0.121	0.956	1.06	1.86	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.